{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:13:51Z","timestamp":1782188031905,"version":"3.54.5"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>A 69-year-old man, with a known case of metastatic castration-resistant prostate cancer (mCRPC) underwent <jats:sup>68<\/jats:sup>Ga-PSMA PET\/CT and <jats:sup>99m<\/jats:sup>Tc-PSMA for evaluation of disease burden and response assessment to <jats:sup>177<\/jats:sup>Lu-PSMA therapy. <jats:sup>99m<\/jats:sup>Tc-PSMA provided a mirror image of <jats:sup>68<\/jats:sup>Ga-PSMA. This suggests the potential of <jats:sup>99m<\/jats:sup>Tc-PSMA SPECT\/CT for disease evaluation and response assessment to PSMA-based radioligand therapies in advanced-stage mCRPC patients, especially when 68Ga-PSMA PET\/CT is not available.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005754","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T06:01:50Z","timestamp":1741327310000},"page":"802-803","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Can 99mTc-PSMA SPECT\/CT Presenting Mirror Image of 68Ga-PSMA PET\/CT Be Used for Response Assessment to 177Lu-PSMA in Metastatic Castration-Resistant Prostate Cancer?"],"prefix":"10.1097","volume":"50","author":[{"given":"Monika","family":"Hooda","sequence":"first","affiliation":[{"name":"Departments of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0583-3514","authenticated-orcid":false,"given":"Suraj","family":"Kumar","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarika","family":"Prashar","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravimohan","family":"Mavuduru","sequence":"additional","affiliation":[{"name":"Urology, Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8464-7765","authenticated-orcid":false,"given":"Baljinder","family":"Singh","sequence":"additional","affiliation":[{"name":"Departments of Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"R1-20250630","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajur.2018.11.005","article-title":"Metastatic prostate cancer remains incurable, why?","volume":"6","author":"Dong","year":"2019","journal-title":"Asian J Urol"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1078-0432.CCR-22-2875","article-title":"FDA approval summary: lutetium Lu 177 vipivotide tetraxetan for patients with metastatic castration-resistant prostate cancer","volume":"29","author":"Fallah","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R4-20250630","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MNM.0000000000001361","article-title":"Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET\/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality","volume":"42","author":"Singh","year":"2021","journal-title":"Nucl Med Commun"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"15993","DOI":"10.1038\/s41598-022-20280-x","article-title":"Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT\/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial","volume":"12","author":"Zhang","year":"2022","journal-title":"Sci Rep"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/RLU.0000000000001991","article-title":"SPECT\/CT with the PSMA ligand 99mTc-MIP-1404 for whole-body primary staging of patients with prostate cancer","volume":"43","author":"Schmidkonz","year":"2018","journal-title":"Clin Nucl Med"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/pros.23696","article-title":"Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT\/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy","volume":"78","author":"Liu","year":"2018","journal-title":"Prostate"},{"key":"R8-20250630","first-page":"1","article-title":"Direct comparison of 99mTc-PSMA SPECT\/CT and 68Ga-PSMA PET\/CT in patients with prostate cancer","volume":"8","author":"Albalooshi","year":"2020","journal-title":"Asia Ocean J Nucl Med Biol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005754","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:34Z","timestamp":1751299294000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005754","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"2024-11-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}